Skip to Content
Merck

Key Documents

View All Documentation

EHU038171

MISSION® esiRNA

targeting human SRP19

Sign In to View Organizational & Contract Pricing.

Select a Size

Change View

About This Item

NACRES:
NA.51
UNSPSC Code:
41105324
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

description

Powered by Eupheria Biotech

Quality Level

100

product line

MISSION®

form

lyophilized powder

esiRNA cDNA target sequence

GAAGGCGAATCCCCATAAGTAAGGCTGTTGAAAATCCTACAGCTACAGAGATTCAAGATGTATGTTCAGCAGTTGGACTTAACGTATTTCTTGAGAAAAATAAAATGTACTCTAGAGAATGGAATCGTGATGTCCAATACAGAGGCAGAGTCCGGGTCCAGCTCAAACAGGAAGATGGGAGCCTCTGCCTTGTACAGTTCCCATCACGTAAGTCAGTAATGTTGTATGCAGCAGAAATGATACCTAAACTAAAAACAAGGACACAAAAAACAGGAGGTGCTGACCAAAGTCTTCAACAAGGAGAGGGAAGTAAAAAAGGGAAAGGAAAGAAAAAGAAGTAACCTAGTATCAGCATCAAGTATGTGGTACTACTGTAAGAGACATGAATGGAGACTTCTAATTTGTATCGGAGGGAAACAGAAGCTTTTTGTTTGCATCATTTAACTGAACTGTGAACCCTTGTGCCTC

Ensembl | human accession no.

ENSG00000153037

NCBI accession no.

NM_003135

shipped in

ambient

storage temp.

−20°C

Gene Information

human ... SRP19(6728)

General description

MISSION® esiRNA are endoribonuclease prepared siRNA. They are a heterogeneous mixture of siRNA that all target the same mRNA sequence. These multiple silencing triggers lead to highly-specific and effective gene silencing.

For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.

Legal Information

MISSION is a registered trademark of Merck KGaA, Darmstadt, Germany

Storage Class

10 - Combustible liquids

flash_point_f

Not applicable

flash_point_c

Not applicable

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
QCS
DOR

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Abhik K Banerjee et al.
Cell, 183(5), 1325-1339 (2020-10-21)
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a recently identified coronavirus that causes the respiratory disease known as coronavirus disease 2019 (COVID-19). Despite the urgent need, we still do not fully understand the molecular basis of SARS-CoV-2 pathogenesis. Here